Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2000529	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2020-10-22	Lilly France	Lilly France	In Review	2020-10-21	view
JYSB2000528	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2020-10-22	Lilly France	Lilly France	In Review	2020-10-21	view
JYSB2000505	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2020-10-13	Lilly France	Lilly France	Certificate Issued	2020-11-26	view
JYHB2001981	注射用盐酸吉西他滨	Gemcitabine hydrochloride	Lyophilized	Chemical Drugs	Supplementary Application	2020-10-13	LILLY FRANCE	Lilly France	Filed	2020-10-26	view
JYSB2000504	重组人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2020-10-13	Lilly France	Lilly France	Certificate Issued	2020-11-26	view
JYSB2000508	精蛋白锌重组人胰岛素混合注射液		Injection	Biological Products	Supplementary Application	2020-10-13	Lilly France	Lilly France	Certificate Issued	2020-11-26	view
JYSB2000503	重组人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2020-10-13	Lilly France	Lilly France	Certificate Issued	2020-11-26	view
JYSB2000507	精蛋白锌重组人胰岛素混合注射液		Injection	Biological Products	Supplementary Application	2020-10-13	Lilly France	Lilly France	Certificate Issued	2020-11-26	view
JYSB2000506	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2020-10-13	Lilly France	Lilly France	Certificate Issued	2020-11-26	view
JYHB2001982	注射用盐酸吉西他滨	Gemcitabine hydrochloride	Lyophilized	Chemical Drugs	Supplementary Application	2020-10-13	LILLY FRANCE	Lilly France	Filed	2020-10-26	view
JYSB2000472	重组人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2020-09-27	Lilly France	Lilly France	Filed	2020-10-19	view
JYSB2000473	重组人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2020-09-27	Lilly France	Lilly France	Filed	2020-10-19	view
JYSB2000439	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2020-09-08	Lilly France	Lilly France	Filed	2020-09-18	view
JYSB2000437	重组人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2020-09-08	Lilly France	Lilly France	Filed	2020-09-18	view
JYSB2000438	重组人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2020-09-08	Lilly France	Lilly France	Filed	2020-09-18	view
JYSB2000442	精蛋白锌重组人胰岛素混合注射液		Injection	Biological Products	Supplementary Application	2020-09-08	Lilly France	Lilly France	Filed	2020-09-18	view
JYSB2000441	精蛋白锌重组人胰岛素混合注射液		Injection	Biological Products	Supplementary Application	2020-09-08	Lilly France	Lilly France	Filed	2020-09-18	view
JYSB2000440	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2020-09-08	Lilly France	Lilly France	Filed	2020-09-18	view
JYHB2001560	注射用盐酸吉西他滨	Gemcitabine hydrochloride	Lyophilized	Chemical Drugs	Supplementary Application	2020-08-25	LILLY FRANCE	Lilly France	Filed	2020-09-09	view
JYHB2001559	注射用盐酸吉西他滨	Gemcitabine hydrochloride	Lyophilized	Chemical Drugs	Supplementary Application	2020-08-25	LILLY FRANCE	Lilly France	Filed	2020-09-09	view